Dr. Joel M. Solano, MD

Dr. Solano practices at Retina Institute of California Medical Group, a California Medical Par in La Quinta, California.

Dr. Solano's NPI, 1952380834, was assigned on January 10, 2006. Dr. Solano graduated from Mayo Clinic Alix School of Medicine - Rochester in 2003. Dr. Solano holds California license C146976.

Dr. Solano's primary practice is Retina Institute of California Medical Group, a California Medical Par, at 47474 Washington St, La Quinta, CA 92253 in Riverside County. The practice phone is (760) 564-2500.

Dr. Solano's primary practice is Retina Institute of California Medical Group, a California Medical Par in La Quinta, California. Dmand AI also links Dr. Solano to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Solano practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Solano's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Solano is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Solano's licenses on file in 6 states: California, South Dakota, Colorado, Minnesota, North Dakota and Arizona.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions and hypertensive retinopathy among the conditions Dr. Solano treats.

CMS data shows 4,690 Medicare services from Dr. Solano across 11 procedure codes in 2024, for 1,240 Medicare patients. Medicare paid $467,239 for them. Every service was in an office.

CMS counts 1,240 Medicare patients who saw Dr. Solano in 2024. The largest group is 65 to 74, with 493 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Solano's median patient age at 70, with 59% women.

In 2024, Dr. Solano wrote 7,258 Medicare Part D claims for 1,337 patients. 77% of them were for generic drugs. CMS names the drug for 7,204 of them, across 21 drugs with 11 or more claims each, at $272,192 in total drug cost. In 2023, CMS named 8,790 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Solano for performance year 2024, reported individually. Dr. Solano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of cataract surgery by Dr. Solano, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Solano, published from 2006 to 2015. The most frequent topics are Phacoemulsification. Dr. Solano's most frequent co-authors are Sophie J. Bakri, MD, John Palmer Berdahl, MD and David F. Chang, MD.

CMS Open Payments shows 21 general payments to Dr. Solano from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Thea Pharma Inc. paid the most, $6,407.

Dmand AI lists 1 award for Dr. Solano, most recently CMS Stage 1 EHR in 2013.

Dr. Solano graduated from Mayo Clinic Alix School of Medicine - Rochester in 2003.

Dr. Solano is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.